A University of Virginia researcher has received a five-year, $2.1 million National Institutes of Health grant to develop ...
Q2 2026 earnings call: raised EBITDA/EPS/FCF outlook, stronger margins and buybacks, PFAS filtration growth, APT sale progress—read ...
KraussMaffei develops high-resolution, smart heating for load-optimized organosheets and blanks for consistent high-rate ...
Rangeview will develop advanced superalloy castings for Kratos turbine engines, helping strengthen U.S. manufacturing ...
Southern Nevada is set to add another large-scale renewable energy project after federal land managers advanced a new solar ...
A new Federal Communications Commission order goes far, far beyond banning just humanoid robots, and will leave Apple Home ...
Earnings beat plus sharply higher guidance (Q1 FY27 EPS $2.15 vs $1.84; revenue $8.1B vs $7.11B) confirms AI-driven memory ...
Inflammatory bowel diseases IBD represent a challenging field in chronic illness, marked by persistent symptoms, fluctuating disease courses, and ...
Spread the love“`html We all have those cherished old photos, don’t we? The ones tucked away in shoeboxes, faded by time, or ...
Artificial intelligence's true revolutionary impact stems from its convergence with other advanced technologies ...
These cosmic giants might one day propel our spacecraft, process unimaginable amounts of data, and even reveal advanced ...
The FDA's target action date under the Class 1 resubmission is August 2, 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results